- Home
- Life Sciences
- Pharmaceutical
- Drug and Medication
- Drug and Medication Analysis & Statistics in France, January 2013 (p2)
Talk to Robyn
(866) 682 9815
Search inside this page
Publication dates
Publishers
- Global Data (39)
- Global Research & Data Services (7)
- Business Monitor International (24)
- Datamonitor (20)
- VacZine Analytics Group Of Assay Advantage Ltd (10)
-
- Euromonitor International (5)
- ICD Research (4)
- SCRIP Insights (3)
- Business Review (2)
- Firstword Pharma (2)
- GBI Research (2)
- Global Industry Analyst (2)
- Barnes Reports (1)
- Daedal Research (1)
- DrugPatentWatch - ThinkBiotech LLC (1)
- Espicom Business Intelligence (1)
- Ken Research Private (1)
- Koncept Analytics (1)
- MarketLine (1)
- Urch Publishing (1)
- Visiongain (1)
- World Market Intelligence Ltd (1)
data types
Free Market Research Guides to Download
Drug and Medication Analysis & Statistics in France, January 2013 (p2)
You might be interested in: drug, vaccine, insulin, more »
» Purchase Premium Reports
31-70 of about 100 reports
France Vaccine Exports, Eurmn
- $ 250
- Industry data
- January 2013
Yearly, From 2002 To 2010
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI
- Industries : Drug and Medication
- Countries : France
France Vaccine Exports, Eurmn, % Y-o-y
- $ 250
- Industry data
- January 2013
Yearly, From 2003 To 2010
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI
- Industries : Drug and Medication
- Countries : France
France Vaccine Imports, Us$mn, % Y-o-y
- $ 250
- Industry data
- January 2013
Yearly, From 2003 To 2010
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI
- Industries : Drug and Medication
- Countries : France
France Vaccine Imports, Eurmn
- $ 250
- Industry data
- January 2013
Yearly, From 2002 To 2010
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI
- Industries : Drug and Medication
- Countries : France
France Vaccine Exports, Us$mn, % Y-o-y
- $ 250
- Industry data
- January 2013
Yearly, From 2003 To 2010
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI
- Industries : Drug and Medication
- Countries : France
France Pharmaceutical Sales, % Of Gdp
- $ 250
- Industry data
- January 2013
Yearly, From 2004 To 2021
By Business Monitor International
Source: LEEM (les entreprises du m?dicament), Association of the European Self-Medication Industry (AESGP),
- Industries : Drug and Medication
- Countries : France
France Pharmaceutical Sales, Eurbn, % Chg Y-o-y
- $ 250
- Industry data
- January 2013
Yearly, From 2005 To 2021
By Business Monitor International
Source: LEEM (les entreprises du m?dicament), Association of the European Self-Medication Industry (AESGP),
- Industries : Drug and Medication
- Countries : France
France Pharmaceutical Sales At Constant Exchange Rate, Us$bn
- $ 250
- Industry data
- January 2013
Yearly, From 2004 To 2021
By Business Monitor International
Source: LEEM (les entreprises du m?dicament), Association of the European Self-Medication Industry (AESGP),
- Industries : Drug and Medication
- Countries : France
France Pharmaceutical Sales, Us$ Per Capita
- $ 250
- Industry data
- January 2013
Yearly, From 2004 To 2021
By Business Monitor International
Source: LEEM (les entreprises du m?dicament), Association of the European Self-Medication Industry (AESGP),
- Industries : Drug and Medication
- Countries : France
France Pharmaceutical Sales, Us$bn, % Chg Y-o-y
- $ 250
- Industry data
- January 2013
Yearly, From 2005 To 2021
By Business Monitor International
Source: LEEM (les entreprises du m?dicament), Association of the European Self-Medication Industry (AESGP),
- Industries : Drug and Medication
- Countries : France
Antibiotics Markets - Top 10 Global Countries Package
- $ 5 174
- Industry report
- September 2012
- by Global Research & Data Services
This market research report package offers a perspective on the actual market situation, trends and future outlook for antibiotics in the top 10 global countries. The studies provide essential market information ...
- Industries : Drug and Medication
- Countries : World, United States, United Kingdom, Canada, Russian Federation, Italy, France, Germany, Japan, India, China, Europe
Pharma and Payers - Building Better Relationships
- $ 895
- Industry report
- September 2012
- by Firstword Pharma
Changes in the healthcare landscape have put payers (public and private) under mounting pressure to reduce the cost of care, and given them much greater influence over market access to new medicines. ...
- Industries : Drug and Medication
- Countries : United States, France, Germany, Europe
Global Active Pharmaceutical Ingredients (API) and High Potency API (HPAPI) Industry Outlook to 2016 - Shifting Focus Towards Biotechnology
- $ 1 200
- Industry report
- September 2012
- by Ken Research Private
EXECUTIVE SUMMARY The report titled ?Global Active Pharmaceutical Ingredients (API) and High Potency API (HPAPI) Industry Outlook to 2016 - Shifting Focus Towards Biotechnology? provides a comprehensive ...
- Industries : Drug and Medication
- Countries : World, Europe, North America, India, China, United States, Canada, Italy, Germany, France, Spain, Japan, United Kingdom, Asia
MarketVIEW: Acne vaccines
- $ 8 995
- Industry report
- September 2012
- by VacZine Analytics Group Of Assay Advantage Ltd
Acne vulgaris is a common skin condition which is estimated to affect 80% of people at some point between 11 and 30 years of age. The condition ranges from mild to severe with latter more likely to cause ...
- Industries : Drug and Medication
- Countries : United States, Australia, Canada, Spain, Italy, France, Germany, Japan
Market Forecasts: Seasonal Influenza Vaccines - Broadened recommendations and increased awareness boost sales in the seasonal influenza vaccine market
- $ 11 400
- Industry report
- August 2012
- by Datamonitor
The large public attention associated with the influenza A (H1N1, swine flu) pandemic in 2009 increased awareness of the importance of seasonal influenza vaccination. Datamonitor predicts that the seasonal ...
- Industries : Drug and Medication
- Countries : France, Spain, Italy, Germany, Japan, United States, United Kingdom, Europe
Les Laboratoires Servier : Company Profile and SWOT Analysis
- $ 120
- Company report
- July 2012
- by World Market Intelligence Ltd
Synopsis World Market Intelligence's 'Les Laboratoires Servier : Company Profile and SWOT Analysis' contains in depth information and data about the company and its operations. The profile contains a company ...
- Industries : Drug and Medication
- Countries : France, World, Canada, Europe, South America
MarketVIEW: Candida vaccines
- $ 7 995
- Industry report
- July 2012
- by VacZine Analytics Group Of Assay Advantage Ltd
Candida yeasts cause Candidiasis which is a fungal infection commonly found in humans. Infections can occur in the female Genital area "vulvovaginal candidiasis" of which nearly 75% of all adult women ...
- Industries : Drug and Medication
- Countries : Australia, Canada, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe, World, Oceania
MarketVIEW: Herpes Simplex Virus vaccines (therapeutic)
- $ 8 995
- Industry report
- July 2012
- by VacZine Analytics Group Of Assay Advantage Ltd
Herpes Simplex Virus (HSV) is a sexually transmitted virus which is a major cause of genital herpes (GH). Although most individuals infected with HSV-2 have minimal signs of infection, the disease is ...
- Industries : Drug and Medication
- Countries : United States, United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, World
France Drug Sector: Sector Report
- $ 800
- Industry report
- July 2012
- by Daedal Research
This industry profile is an essential tool to help your company gain an in-depth knowledge and competitive advantage in the industry. The profile is an assimilation of insider knowledge, market characteristics ...
- Industries : Drug and Medication
- Countries : France
France Pharmaceuticals and Healthcare Industry Update Quarter 3 2012
- $ 1 088
- Industry report
- June 2012
- by Business Monitor International
Includes 3 FREE quarterly updates BMI View: With the aim of improving patient safety and restoring confidence in the country's drug regulatory process, in December 2011 the French parliament approved ...
- Industries : Drug and Medication
- Countries : France
Biopharmaceutical: Hepatitis A Preventive Vaccines
- $ 3 995
- Company report
- June 2012
- by Global Data
GlobalData, the market analysis specialist, has released its new report, ??. The report is an essential source of information and analysis on the global Hepatitis A Preventive Vaccines industry . The ...
- Industries : Drug and Medication
- Countries : Japan, Spain, Italy, France, Germany, United States, World, Europe, United Kingdom
MarketVIEW: Chlamydia trachomatis vaccines
- $ 8 995
- Industry report
- June 2012
- by VacZine Analytics Group Of Assay Advantage Ltd
Chlamydia trachomatis (CT) is an intracellular Gram-negative bacterium and a leading cause worldwide of sexually-transmitted disease and preventable blindness. The pathogen is a major cause of serious ...
- Industries : Drug and Medication
- Countries : Australia, World, Brazil, United States, Mexico, Canada, United Kingdom, Spain, Russian Federation, Italy, France, Germany, Japan, India, China, Europe
MarketVIEW: Cytomegalovirus vaccines
- $ 9 995
- Industry report
- June 2012
- by VacZine Analytics Group Of Assay Advantage Ltd
Cytomegalovirus (CMV) is a member of the herpesvirus family and is widely prevalent throughout the population. In the US around 50-80% of adults are infected by 40 years of age (US CDC figures) whereas ...
- Industries : Drug and Medication
- Countries : United States, Canada, Spain, Italy, France, Germany, Japan, Europe, United Kingdom, World
France Drug Market Research
- $ 600
- Industry report
- June 2012
- by Koncept Analytics
This market profile helps to gain an insight into the evolution of the market and competitive dynamics prevalent in the industry . It discusses the significant developments in the market and analyzes the ...
- Industries : Drug and Medication
- Countries : France
Market and Product Projections : Non-Insulin Antidiabetics ? - Incretin mimetics face off Market Overview in type 2 diabetes
- $ 11 400
- Industry report
- May 2012
- by Datamonitor
The 2011'20 projection period will see the loss of exclusivity for the leading non-insulin antidiabetic Actos franchise, while new launches include the first once-weekly GLP-1 agonists and the oral SGLT-2 ...
- Industries : Drug and Medication
- Countries : Japan, Spain, Italy, France, Germany, United States, Europe, United Kingdom
Insulin - France
- $ 652
- Industry report
- May 2012
- by Global Research & Data Services
This market research report offers a perspective on the actual market situation, trends and future outlook for insulin in France. The study provides essential market information for decision-makers including: ...
- Industries : Drug and Medication
- Countries : France
Analgesics Market Analysis in France
- $ 898
- Industry report
- April 2012
- by Euromonitor International
However, there remained a lack of investment within the aspirin category, which partly explains the modest performance of analgesics in 2010. Aspirin continued to be threatened by consumers? preference ...
- Industries : Drug and Medication
- Countries : France
Cough, Cold and Allergy (Hay Fever) Remedies Market Analysis in France
- $ 898
- Industry report
- April 2012
- by Euromonitor International
In general, consumers are used to self-medicating with products from this category and they did not change their habits in 2010. However, the category faced stronger competition from some homoeopathic ...
- Industries : Drug and Medication
- Countries : France
NRT Smoking Cessation Aids Market Analysis in France
- $ 898
- Industry report
- April 2012
- by Euromonitor International
However this legislation, put into force some years ago, seems to have reached its limits in terms of impact, as... Euromonitor International's report offers a comprehensive guide to the size and shape ...
- Industries : Drug and Medication
- Countries : France
Digestive Remedies Market Analysis in France
- $ 898
- Industry report
- April 2012
- by Euromonitor International
This new category of products came to extend the digestive remedies category as a whole, being largely responsible for the growth of 10% observed in 2010. Euromonitor International's report offers a comprehensive ...
- Industries : Drug and Medication
- Countries : France
MarketVIEW: Staphylococcus aureus vaccines
- $ 9 995
- Industry report
- April 2012
- by VacZine Analytics Group Of Assay Advantage Ltd
Gram-positive Staphylococcus aureus is an opportunistic pathogen and a major cause of patient morbidity and mortality, especially in "at risk" populations. The organism can cause a wide range of infections ...
- Industries : Drug and Medication
- Countries : United States, France, Germany, Europe, Australia, Canada, United Kingdom, Spain, Italy, Japan, World
Vaccines - France
- $ 652
- Industry report
- March 2012
- by Global Research & Data Services
This market research report offers an in-depth perspective on the actual market situation, trends and future outlook for vaccines in France. The analysis provides essential market information for decision-makers ...
- Industries : Drug and Medication
- Countries : France
Haemophilus Influenzae Type B (Hib) Vaccine - Pipeline Assessment and Market Forecasts to 2019
- $ 3 995
- Company report
- February 2012
- by Global Data
Haemophilus Influenzae Type B (Hib) Vaccine - Pipeline Assessment and Market Forecasts to 2019 Summary GlobalData, the industry analysis specialist, has released its new report, ?Haemophilus Influenzae ...
- Industries : Drug and Medication
- Countries : World, Japan, Spain, Italy, France, Germany, United States, Europe, United Kingdom
Tiered Pricing Strategies in Emerging Markets
- $ 695
- Industry report
- February 2012
- by Firstword Pharma
For the pharmaceutical industry, emerging markets are dynamic, full of potential and offer solid growth at a time when established markets are contracting. But they also pose a significant problem: extreme ...
- Industries : Drug and Medication
- Countries : United Kingdom, Switzerland, France
MarketVIEW: Universal pneumo vaccines
- $ 9 995
- Industry report
- January 2012
- by VacZine Analytics Group Of Assay Advantage Ltd
Vaccines to prevent serious infections caused by Streptococcus pneumoniae or "pneumo" currently form the largest component of the global vaccine market ($4 - 5bn/yr). Notable examples are Prevnar/Prevena ...
- Industries : Drug and Medication
- Countries : South Korea, Europe, World, Australia, Netherlands, United States, Canada, Spain, Portugal, Poland, Italy, Greece, France, Germany, Belgium, Japan, United Kingdom, Bangladesh, Brazil, Mexico, Gambia
France Drug Patent Inventor Report - 2011
- $ 395
- Industry report
- January 2012
- by DrugPatentWatch - ThinkBiotech LLC
Profiles French drug inventors who have received USPTO patents for FDA-approved drugs since 2000
- Industries : Drug and Medication
- Countries : France
Drug Eluting Balloons (DEB) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
- $ 3 500
- Industry report
- December 2011
- by Global Data
Drug Eluting Balloons (DEB) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Summary GlobalData's new report, ?Drug Eluting Balloons (DEB) - Global Pipeline Analysis, Competitive ...
- Industries : Drug and Medication
- Countries : World, Australia, Spain, Italy, France, Germany, India, China, Europe, United Kingdom, Oceania, Asia
Les Laboratoires Servier: Company Profile and SWOT Analysis
- $ 99
- Company report
- November 2011
- by ICD Research
Synopsis ICD Research's "Les Laboratoires Servier: Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, ...
- Industries : Drug and Medication
- Countries : France
Market and Product Projections : COPD - ? Growth expected despite untapped industry potential
- $ 11 400
- Industry report
- November 2011
- by Datamonitor
About This Report New product launches for COPD across the seven major industry s will override generic erosion and boost industry value from USD 8.2bn in 2011 to USD 9.6bn by 2020, representing a positive ...
- Industries : Drug and Medication
- Countries : Spain, Italy, France, Germany, Japan
Sanofi-Aventis: Company Profile and SWOT Analysis
- $ 99
- Company report
- November 2011
- by ICD Research
Synopsis ICD Research's "Sanofi-Aventis: Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, business ...
- Industries : Drug and Medication
- Countries : France
» Download Public Reports
51 reports
Company Report: Drug and Medication in France and The United States for Year 2012
- Company report
- July 2012
- 2 pages
... And development, future clinical data and analysis, including post marketing, s by regulatory authorities, such as the fda or the ema, regarding whether and when to approve any drug, device or biological ...
Company Report: Drug And Medication In France For Year 2012
September 2012The European Medicine Industry Brief
May 2012Drug Sector In France
March 2013Vaccine Market In The United States And France
September 2012World Drug And Medication Industry
March 2013The French Antibiotic Industry Analysis
October 2012» Read our Company Profiles
1 CompaniesGlaxoSmithKline P.L.C.
United StatesReportlinker.com © Copyright 2013. All rights reserved.
